Effects of Intravenous Lidocaine as an Analgesic Adjuvant in Oncological Pain
Abstract
Objectives: To verify that intravenous lidocaine is effective as an adjuvant analgesic in pain for hospitalized cancer patients at the National Institute of Cancerology, Mexico. Methods: Clinical records of patients hospitalized at the National Institute of Cancerology who received intravenous lidocaine infusion as an adjuvant to pain during the 4-year period from November 1, 2019, to October 31, 2023, were reviewed. Patients who met inclusion and exclusion criteria were included. A statistically significant measure was defined as a decrease equal to or greater than 4 points in the NRS value after lidocaine administration.
Results: A total of 179 patients were included; 46.4% were men, and 53.6% were women. The most common painful syndrome was somatic (54%). Patients with neuropathic pain received a higher lidocaine dose (mg/kg/hr) of 1.9 ± 0.79. Regarding adverse effects, 1.7% of patients experienced them. It was established that a reduction of 4 points with respect to the previous value on the numeric rating scale (NRS) would be considered statistically significant. A statistically significant association was found between patients under 38 years old and a higher risk of not achieving the objective (p 0.05, CI 0.95–1 OR 0.9). Patients who received lidocaine infusions for less than 4.63 days also had a risk of not reaching the goal (p 0.02, CI 0.7–0.9, OR 0.8).
Conclusions: This study demonstrated that the analgesic adjuvant use of intravenous lidocaine infusion is an effective and well-tolerated analgesic intervention for oncology patients.
Keywords: lidocaine, Neuropathic Pain, Somatic Pain, Visceral Pain, numeric rating scale.
Keywords:
lidocaine, Neuropathic Pain, Somatic Pain, Visceral Pain, numeric rating scaleDOI
https://doi.org/10.22270/jddt.v14i2.6418References
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020 (https://gco.iarc.fr/today)
Srinivasa N. Rajaa, Daniel B. Carrb, Milton Cohenc, Nanna B. Finnerupd, Herta Florf, Stephen Gibsong, Francis J. Keefeh, Jeffrey S. Mogili, Matthias Ringkampj, Kathleen A. Slukak, Xue-Jun Songl, Bonnie Stevensm, Mark D. Sullivann, Perri R. Tutelmano, Takahiro Ushidap, Kyle Vader. "The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises." PAIN 2020;(00):1-7 https://doi.org/10.1097/j.pain.0000000000001939 PMid:32694387 PMCid:PMC7680716
Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavand'homme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, Rice ASC, Rowbotham MC, Schug S, Simpson DM, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Barke A, Rief W, Treede RD; Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). "The IASP classification of chronic pain for ICD-11: chronic neuropathic pain." PAIN 2019;(160):53-59. https://doi.org/10.1097/j.pain.0000000000001365 PMid:30586071 PMCid:PMC6310153
Merskey H, Bogduk N, Classification of Chronic Pain, Second Edition (Revised). Part III: Pain Terms, "A Current List with Definitions and Notes on Usage" ed. Seattle: IASP Press. 1994. PP. 209-214.
Fernandes V, Sharma D, Vaidya Sh et al. "Cellular and molecular mechanism driving neuropathic pain: Recent advancements and challenges" Taylor and Francis Online 2017;12-21 https://doi.org/10.1080/14728222.2018.1420781 PMid:29285962
Qi FH, Zhou YL, Xu GY. Targeting voltage-gated sodium channels for treatment for chronic visceral pain. World J Gastroenterol 2011 May 21;17(19):2357-64. https://doi.org/10.3748/wjg.v17.i19.2357 PMid:21633634 PMCid:PMC3103787
Velilla Echeverri DC, Gómez Díaz M, Beltrán Pachón P, Lasso Valenzuela D, Poveda Carreño S, Erazo-Muñoz M. "Lidocaine infusion for malignant visceral pain: case report" BMJ Support Palliat Care 2023; Jul 3:spcare-2023-004350. https://doi.org/10.1136/spcare-2023-004350 PMid:37400161
Plaghki L, Mouraux A, Le Bars D. "Fisiología del dolor". Volume 39 n◦1 febrero ELSEVIER MASSON 2018; E-26-007-E-10 https://doi.org/10.1016/S1293-2965(18)88603-0
De Oliveira K, Eipe N. "Intravenous Lidocaine for Acute Pain: A Single-Institution Retrospective Study". Drugs Real World Outcomes. 2020 Sep;7(3):205-212. https://doi.org/10.1007/s40801-020-00205-8 PMid:32648241 PMCid:PMC7392972
Bahar, Entaz, and Hyonok Yoon. "Lidocaine: A Local Anesthetic, Its Adverse Effects and Management." Medicina (Kaunas, Lithuania) 2021;57(8):782. https://doi.org/10.3390/medicina57080782 PMid:34440986 PMCid:PMC8399637
Resiana K et al. "Molecular mechanisms of lidocaine." Annals of medicine and surgery 2012. 2021;69:102733. https://doi.org/10.1016/j.amsu.2021.102733
Mayhew A, Argáez C. "Intravenous Lidocaine for Chronic Pain: A Review of the Clinical Effectiveness and Guidelines." Canadian Agency for Drugs and Technologies in Health (2018) https://www.ncbi.nlm.nih.gov/books/NBK531808/
Yang, X., Wei, X., Mu, Y., Li, Q., & Liu, J. "A review of the mechanism of the central analgesic effect of lidocaine". Medicine". 2020;99(17), e19898. https://doi.org/10.1097/MD.0000000000019898 PMid:32332666 PMCid:PMC7440315
Vincent A, Bernard YM. "Farmacología de los anestésicos locales" Anestesia-Reanimación, Elsevier Masson 2018;1:1-19, https://doi.org/10.1016/S1280-4703(18)41552-6
Soto G, Nanjo M, Calero F. "Pefusión de lidocaína intravenosa" Revista Española de Anestesiología y Reanimación 2018;65(5):269-274 https://doi.org/10.1016/j.redar.2018.01.004 PMid:29496229
Rodney A. Gabriel, Matthew W. Swisher, Jacklynn F. Sztain, Timothy J. Furnish, Brian M. Ilfeld & Engy T. Said "State of the art opioid-sparing strategies for post-operative pain in adult surgical patients" Expert Opinion on Pharmacotherapy 2019;20(8):949-961, https://doi.org/10.1080/14656566.2019.1583743 PMid:30810425
Lee, James H. MD; Koutalianos*, Dra. Evangeline P†; Leimer, Elizabeth M. MD, PhD‡; Bhullar, Ravneet K. MD; Argoff, Charles E. MD. "Lidocaína intravenosa en el dolor neuropático crónico: Una revisión sistemática" The Clinical Journal of Pain 2022;38(12):739-748 https://doi.org/10.1097/AJP.0000000000001080 PMid:36288104
Horvat S, Staffhorst B, Cobben JHMG. "Intravenous Lidocaine for Treatment of Chronic Pain: A Retrospective Cohort Study". Journal of Pain Research 2022;15:3459-3467 https://doi.org/10.2147/JPR.S379208 PMid:36329833 PMCid:PMC9624148
Wilderman I, Pugacheva O, Perelman VS, Wansbrough MCT, Voznyak Y, Zolnierczyk L. "Repeated intravenous lidocaine infusions for patients with fibromyalgia: Higher doses of lidocaine have a stronger and longer-lasting effect on pain reduction". PainMed (2020) https://doi.org/10.1093/pm/pnz251 PMid:31621870
Lee JT, Sanderson CR, Xuan W, Agar M. "Lidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis". J Palliat Med. 2019 Mar;22(3):326-334. https://doi.org/10.1089/jpm.2018.0257 PMid:30614748
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for Adult Cancer Pain V.2.2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. To view the most recent and complete version of the guideline, go online to NCCN.org
Abouelmagd GMT, El-Karadawy SA, Abo-Ollo MM, Elwany YN, Mohamed ER, El-Amrawy WZ. Lidocaine Infusion Versus Duloxetine for Prevention and Management of Taxane-Induced Peripheral Neuropathy among Breast Cancer Patients-A Randomized Controlled Study. Pain Physician. 2023 Sep;26(5):E497-507. https://pubmed.ncbi.nlm.nih.gov/37774185/
Marret E, Rolin M, Beaussier M, Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008;95(11):1331-8. https://doi.org/10.1002/bjs.6375 PMid:18844267
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).